Where does Therini Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Therini Bio's 2 recorded funding rounds.

Premier Alternatives

Therini Bio

Sacramento, CA · Founded 2016 · Privately Held (backing)

Developer of biotechnology drugs designed to offer a potential treatment to protect the nervous system from multiple sclerosis damage. Therini Bio is based in Sacramento, CA and was founded in 2016. It was valued at $100 million at its later-stage round in May 2025, the last priced event on record. It has raised $102 million across 2 recorded rounds; the latest was a $74.9 million later-stage round in Mar 2023.

PMV mark · valuation

$100.0M

Oct 2026

Priced at

its later-stage round

May 2025

Total raised

$101.5M

Last round

Later Stage VC

Mar 2023

Cap table — not yet on record

Therini Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Therini Bio with a free account

·The complete investor list: 15 names
·Watch Therini Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Therini Bio

Where does Therini Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Therini Bio's 2 recorded funding rounds.